The story of Viagra, originally marketed by copyright, presents a fascinating case study for investors considering the drug landscape . While its groundbreaking success and generation of vast in revenue , the patent lapse has opened the way for alternative medications, substantially reducing income opportunities. This shift raises doubts about the